SAREMASLANI P[au] - Search Results

Year	Number of Results
1981	1
1982	2
1983	2
1985	1
1986	1
1989	2
1990	1
1991	1
1992	2
1994	3
1995	3
1996	5
1998	2
1999	5
2000	3
2001	6
2002	2
2003	2
2004	6
2005	2
2006	1
2023	0

1

Abnormalities of proinsulin processing in functioning insulinomas: clinical implications.

Wiesli P, Perren A, Saremaslani P, Pfammatter T, Spinas GA, Schmid C. Wiesli P, et al. Among authors: saremaslani p. Clin Endocrinol (Oxf). 2004 Oct;61(4):424-30. doi: 10.1111/j.1365-2265.2004.02095.x. Clin Endocrinol (Oxf). 2004. PMID: 15473873

2

Histogenesis and differentiation potential of central neurocytomas.

von Deimling A, Kleihues P, Saremaslani P, Yasargil MG, Spoerri O, Südhof TC, Wiestler OD. von Deimling A, et al. Among authors: saremaslani p. Lab Invest. 1991 Apr;64(4):585-91. Lab Invest. 1991. PMID: 1901927

3

RET proto-oncogene point mutations in sporadic neuroendocrine tumors.

Komminoth P, Roth J, Muletta-Feurer S, Saremaslani P, Seelentag WK, Heitz PU. Komminoth P, et al. Among authors: saremaslani p. J Clin Endocrinol Metab. 1996 Jun;81(6):2041-6. doi: 10.1210/jcem.81.6.8964826. J Clin Endocrinol Metab. 1996. PMID: 8964826

4

MEN1 gene mutation analysis of sporadic adrenocortical lesions.

Görtz B, Roth J, Speel EJ, Krähenmann A, De Krijger RR, Matias-Guiu X, Muletta-Feurer S, Rütmann K, Saremaslani P, Heitz PU, Komminoth P. Görtz B, et al. Among authors: saremaslani p. Int J Cancer. 1999 Jan 29;80(3):373-9. doi: 10.1002/(sici)1097-0215(19990129)80:3<373::aid-ijc7>3.0.co;2-b. Int J Cancer. 1999. PMID: 9935177 Free article.

5

Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.

Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Komminoth P, Heitz PU. Mihic-Probst D, et al. Among authors: saremaslani p. Anticancer Res. 2004 Jul-Aug;24(4):2415-8. Anticancer Res. 2004. PMID: 15330192 Free article.

6

IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.

Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A. Schmitt A, et al. Among authors: saremaslani p. Histopathology. 2006 Sep;49(3):298-307. doi: 10.1111/j.1365-2559.2006.02505.x. Histopathology. 2006. PMID: 16918977

7

Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.

Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, Weihe E, Komminoth P, Heitz PU, Klöppel G. Anlauf M, et al. Among authors: saremaslani p. Gastroenterology. 2005 May;128(5):1187-98. doi: 10.1053/j.gastro.2005.01.058. Gastroenterology. 2005. PMID: 15887103

8

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S. Leung C, et al. Among authors: saremaslani p. Nature. 2004 Mar 18;428(6980):337-41. doi: 10.1038/nature02385. Nature. 2004. PMID: 15029199

9

ALG-2: a Ca2+ -binding modulator protein involved in cell proliferation and in cell death.

Krebs J, Saremaslani P, Caduff R. Krebs J, et al. Among authors: saremaslani p. Biochim Biophys Acta. 2002 Nov 4;1600(1-2):68-73. doi: 10.1016/s1570-9639(02)00446-6. Biochim Biophys Acta. 2002. PMID: 12445461

10

CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors.

Komminoth P, Seelentag WK, Saremaslani P, Heitz PU, Roth J. Komminoth P, et al. Among authors: saremaslani p. Histochem Cell Biol. 1996 Dec;106(6):551-62. doi: 10.1007/BF02473270. Histochem Cell Biol. 1996. PMID: 8985743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results